ContractRestricted Stock Inducement Award Agreement • March 18th, 2004 • Medtox Scientific Inc • Services-medical laboratories • Delaware
Exhibit 10.25 RESTRICTED STOCK INDUCEMENT AWARD AGREEMENT (Shares not issued under the Equity Compensation Plan) THIS RESTRICTED STOCK AWARD AGREEMENT (the "Agreement") reflects the offer of an inducement award of Restricted Stock pursuant to the terms set forth herein as of this 3rd day of December, 2003, by MEDTOX Scientific, Inc. (formerly EDITEK, Inc.), a Delaware corporation, to Robert C. Bohannon (the "Participant"). For valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 1. Defined Terms. Unless the context clearly requires otherwise, capitalized terms shall have the meaning specified in the MEDTOX Scientific, Inc. Equity Compensation Plan (the “Plan”). 2. Award. The Committee hereby offers to Participant 5,500 shares of MEDTOX Scientific, Inc. (the “Restricted Stock”). These shares of stock are not being offered as part of the Equity Compensation Plan. Unless this offer of Restricted Stock is accepted an
ContractNonqualified Inducement Stock Option Agreement • March 18th, 2004 • Medtox Scientific Inc • Services-medical laboratories • Minnesota
Exhibit 10.24 NONQUALIFIED INDUCEMENT STOCK OPTION AGREEMENT (Shares not issued under the Equity Compensation Plan) THIS AGREEMENT is dated effective as of the grant date set forth on Exhibit A attached hereto, between MEDTOX Scientific, Inc., a Delaware corporation (the “Corporation”), and the individual listed on Exhibit A (“Grantee”). WHEREAS, the Corporation desires to grant and the Grantee desires to accept the Stock Options to purchase Common Stock of the Corporation (as defined below); NOW THEREFORE, in consideration of the premises and of the covenants and agreements set forth below, it is mutually agreed as follows: 1. Grant of Options. The Corporation hereby grants to Grantee an Inducement Option to purchase from the Corporation all or any part of an aggregate amount of the shares of the Common Stock of the Corporation, $.15 par value per share (the “Common Stock”), at the Option price and on other terms, as set forth in Exhibit A attached hereto and made a part hereof, and
ContractCredit and Security Agreement • March 18th, 2004 • Medtox Scientific Inc • Services-medical laboratories
Exhibit 10.30 March 5, 2004 FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT This Amendment, dated as of March 5, 2004, is made by and between MEDTOX SCIENTIFIC, INC., a Delaware corporation (“Scientific”), MEDTOX LABORATORIES, INC., a Delaware corporation (“Laboratories”), MEDTOX DIAGNOSTICS, INC., a Delaware corporation (“Diagnostics”), and CONSOLIDATED MEDICAL SERVICES, INC., a Delaware corporation (“Consolidated”, and together with Scientific, Laboratories and Diagnostics, collectively, the “Borrowers”, and each a “Borrower”), and WELLS FARGO BUSINESS CREDIT, INC., a Minnesota corporation formerly known as Norwest Business Credit, Inc. (the “Lender”). Recitals The Borrowers and the Lender are parties to an Amended and Restated Credit and Security Agreement dated as of May 7, 2001 but effective as of March 31, 2001, as amended by a First Amendment to Amended and Restated Credit and Security Agreement dated as of October 24, 2001, a Second Amendment to Amended
ContractLease • March 18th, 2004 • Medtox Scientific Inc • Services-medical laboratories • North Carolina
Exhibit 10.23 AMENDED AND RESTATED LEASE THIS AMENDED AND RESTATED LEASE, is made effective as of the 1st day of November 2003, by and between Powell Enterprises, a sole proprietorship (the “Landlord”), and MEDTOX Diagnostics, Inc., a Delaware corporation (the “Tenant”). RECITALS: A. Landlord and Tenant are parties to that certain Lease dated March 28, 2001, as amended by that certain Amendment No. 1 to Nova Building Lease dated effective as of April 1, 2001 for the property commonly known as the “Nova Building” (the “Nova Lease”). B. Landlord and Tenant are parties to that certain Lease Agreement dated on or about February 1, 2003 for the property commonly known as the “Nypro Building” (the “Nypro Lease”; the Nova Lease and the Nypro Lease are collectively referred to as the “Original Leases”). C. Paragraph 4.03 of the Nova Lease provides that Tenant may elect to have Landlord pay up to $600,000 for improvements to the Premises (defined in the Nova Lease) and that to the extent that L
EFFECTIVE DATE: July 1, 2003 PARTIES: Cox Health, a Missouri corporation Springfield, MO 65802 Fax No. (417) 269-3092 Attn: David Stewart ("Cox") Medtox Laboratories, Inc., a Minnesota corporation St. Paul, MN 55112 Fax No. (651) 628-6150 Attn: Kevin...Purchase and Sale Agreement • March 18th, 2004 • Medtox Scientific Inc • Services-medical laboratories • Minnesota
RECITALS: A. Cox currently performs testing for drugs of abuse (the “Services”) to certain businesses (the “Customers”). B. Medtox desires to purchase from Cox its Customer List (defined below), free and clear of any and all liabilities, liens, claims, charges, security interests, pledges, restrictions and encumbrances of every kind and character (collectively, the “Encumbrances”), subject to the terms and conditions of this Purchase and Sale Agreement (the “Agreement”). C. Cox has agreed to sell the Customer List (defined below) to Medtox subject to the terms and conditions of this Agreement. AGREEMENT: In consideration of the mutual promises set forth herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 1. Sale of Customer List.
ContractCredit and Security Agreement • March 18th, 2004 • Medtox Scientific Inc • Services-medical laboratories
Exhibit 10.27 August 15, 2003 THIRD AMENDMENT TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT This Amendment, dated as of August 15, 2003, is made by and between MEDTOX SCIENTIFIC, INC., a Delaware corporation (“Scientific”), MEDTOX LABORATORIES, INC., a Delaware corporation (“Laboratories”), MEDTOX DIAGNOSTICS, INC., a Delaware corporation (“Diagnostics”), and CONSOLIDATED MEDICAL SERVICES, INC., a Delaware corporation (“Consolidated”, and together with Scientific, Laboratories and Diagnostics, collectively, the “Borrowers”, and each a “Borrower”), and WELLS FARGO BUSINESS CREDIT, INC., a Minnesota corporation formerly known as Norwest Business Credit, Inc. (the “Lender”). Recitals The Borrowers and the Lender are parties to an Amended and Restated Credit and Security Agreement dated as of May 7, 2001 but effective as of March 31, 2001, as amended by a First Amendment to Amended and Restated Credit and Security Agreement dated as of October 24, 2001, and a Second Amendment to
